Evidence map›Paper›PMID 34828328›Full record

ArticleGenes2021

CMAX3: A Robust Statistical Test for Genetic Association Accounting for Covariates.

Zhongxue Chen, Yong Zang

Open access · goldAbstract read
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Zhongxue ChenDepartment of Epidemiology and Biostatistics, School of Public Health, Indiana University Bloomington, Bloomington, IN 47401, USA.ORCID 0000-0003-2537-7843
Yong ZangDepartment of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, IN 46202, USA.
Indiana University Bloomington · USIndiana University – Purdue University Indianapolis · US

Funding

Analyzing nonsyndromic orofacial clefts GWAS data with case-parent trio designR03DE030259 · NIDCR · TRUSTEES OF INDIANA UNIVERSITY · PI CHEN, ZHONGXUE · 2021 to 2022
$345k
Curve-free phase I/II clinical trial designs for molecularly targeted agents and immunotherapyR21CA264257 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI ZANG, YONG · 2021 to 2022
$277k
NCI NIH HHS R21 CA264257NIDCR NIH HHS R03 DE030259
6 · The paper itself

Abstract

The additive genetic model as implemented in logistic regression has been widely used in genome-wide association studies (GWASs) for binary outcomes. Unfortunately, for many complex diseases, the underlying genetic models are generally unknown and a mis-specification of the genetic model can result in a substantial loss of power. To address this issue, the MAX3 test (the maximum of three separate test statistics) has been proposed as a robust test that performs plausibly regardless of the underlying genetic model. However, the original implementation of MAX3 utilizes the trend test so it cannot adjust for any covariates such as age and gender. This drawback has significantly limited the application of the MAX3 in GWASs, as covariates account for a considerable amount of variability in these disorders. In this paper, we extended the MAX3 and proposed the CMAX3 (covariate-adjusted MAX3) based on logistic regression. The proposed test yielded a similar robust efficiency as the original MAX3 while easily adjusting for any covariate based on the likelihood framework. The asymptotic formula to calculate the

Indexed as

Models, GeneticAlgorithmsGenetic Association StudiesHumansLogistic ModelsPhenotypeSoftwaregenetic modelgenotypeGWASMAX3 testphenotyperisk allelescore test

Identifiers

PMID34828328
PMCPMC8622598
OpenAlexW3208866470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.